Tiziana Life Sciences (TLSA) announces that its Executive Chairman and Founder, Mr. Gabriele Cerrone, has purchased 25,000 common shares at $1.60 per share, bringing his total holding to 43,277,143 common shares, which is 36.28% of issued share capital.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSA:
- Tiziana Life Sciences Initiates Phase 2a Trial for MSA with Intranasal Foralumab
- Tiziana Life doses first patient in Phase 2a trial of intranasal foralumab
- FDA Approves Tiziana Life Sciences’ Phase 2a Trial for MSA
- Tiziana Life announces FDA approved IND for Phase 2a trial of foralumab
- Tiziana Life Sciences initiated with a Buy at Lucid Capital